Articles |
the Institute of Biotechnology, Laboratory of Molecular Neurobiology, University of Helsinki (Finland).
Correspondence to Jukka O. Hiltunen, Institute of Biotechnology, Laboratory of Molecular Neurobiology, PO Box 56, Viikinkaari 9, FIN-00014, University of Helsinki, Finland. E-mail juhiltun@cc.helsinki.fi.
Because the neurotrophic system has not been systematically studied in developing heart, we studied the expression of mRNAs for neurotrophins and their high- and low-affinity receptors by radioactive in situ hybridization in the rat heart from embryonic day 9 (E9) to parturition. The neurotrophin-3 (NT-3) transcripts were seen in the group of Leu-7 immunoreactive cells in the ventricular region from E11 to parturition, suggesting that NT-3 is expressed in the part of the developing conduction system. mRNAs for truncated trk receptors, trkC.TK- and trkB.T1, were expressed in the outflow tract at E12 and in the walls of developing aorta and pulmonary trunk from E13 to parturition, whereas the mRNA for catalytic trkC.TK+ was revealed in the walls of aorta and pulmonary trunk from E13 to parturition and in the cardiac ganglion neurons from E14 to adult stage. Transcripts for low-affinity neurotrophin receptor (p75) were transiently seen in the distal outflow tract from E11 to E13, declining by E14. At E18, p75 transcripts were also seen in the cardiac ganglia. Transcripts for nerve growth factor, neurotrophin-4/5, trkA, or trkB.TK+ were not detected. Expression of NT-3 mRNA in the developing conduction system and of trkC.TK+ mRNA in the cardiac neurons suggests a role for NT-3 in the innervation of the conduction system. Expression of trkC.TK+ in the wall of aorta and pulmonary trunk suggests that NT-3 also may affect the development of the smooth muscle cells.
Key Words: neurotrophin embryonic heart in situ hybridization conduction system smooth muscle
This article has been cited by other articles:
![]() |
R. N. Pearse, S. L. Swendeman, Y. Li, D. Rafii, and B. L. Hempstead A neurotrophin axis in myeloma: TrkB and BDNF promote tumor-cell survival Blood, June 1, 2005; 105(11): 4429 - 4436. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Riazi, H. Lee, C. Hsu, and G. Van Arsdell CSX/Nkx2.5 Modulates Differentiation of Skeletal Myoblasts and Promotes Differentiation into Neuronal Cells in Vitro J. Biol. Chem., March 18, 2005; 280(11): 10716 - 10720. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kim, Q. Li, B. L. Hempstead, and J. A. Madri Paracrine and Autocrine Functions of Brain-derived Neurotrophic Factor (BDNF) and Nerve Growth Factor (NGF) in Brain-derived Endothelial Cells J. Biol. Chem., August 6, 2004; 279(32): 33538 - 33546. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Rivera, J. Voipio, J. Thomas-Crusells, H. Li, Z. Emri, S. Sipila, J. A. Payne, L. Minichiello, M. Saarma, and K. Kaila Mechanism of Activity-Dependent Downregulation of the Neuron-Specific K-Cl Cotransporter KCC2 J. Neurosci., May 12, 2004; 24(19): 4683 - 4691. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-Y. Chen, P. D. Patel, G. Sant, C.-X. Meng, K. K. Teng, B. L. Hempstead, and F. S. Lee Variant Brain-Derived Neurotrophic Factor (BDNF) (Met66) Alters the Intracellular Trafficking and Activity-Dependent Secretion of Wild-Type BDNF in Neurosecretory Cells and Cortical Neurons J. Neurosci., May 5, 2004; 24(18): 4401 - 4411. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Rivera, H. Li, J. Thomas-Crusells, H. Lahtinen, T. Viitanen, A. Nanobashvili, Z. Kokaia, M. S. Airaksinen, J. Voipio, K. Kaila, et al. BDNF-induced TrkB activation down-regulates the K+-Cl- cotransporter KCC2 and impairs neuronal Cl- extrusion J. Cell Biol., December 9, 2002; 159(5): 747 - 752. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Donovan, M. Lin, P Wiegn, T Ringstedt, R Kraemer, R Hahn, S Wang, C. Ibanez, S Rafii, and B. Hempstead Brain derived neurotrophic factor is an endothelial cell survival factor required for intramyocardial vessel stabilization Development, January 11, 2000; 127(21): 4531 - 4540. [Abstract] [PDF] |
||||
![]() |
M. E. Palko, V. Coppola, and L. Tessarollo Evidence for a Role of Truncated trkC Receptor Isoforms in Mouse Development J. Neurosci., January 15, 1999; 19(2): 775 - 782. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Tessarollo, P. Tsoulfas, M. J. Donovan, M. E. Palko, J. Blair-Flynn, B. L. Hempstead, and L. F. Parada Targeted deletion of all isoforms of the trkC gene suggests the use of alternate receptors by its ligand neurotrophin-3 in neuronal development and implicates trkC in normal cardiogenesis PNAS, December 23, 1997; 94(26): 14776 - 14781. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Qin, R. S. Vulapalli, S. Y. Stevens, and C.-S. Liang Loss of cardiac sympathetic neurotransmitters in heart failure and NE infusion is associated with reduced NGF Am J Physiol Heart Circ Physiol, January 1, 2002; 282(1): H363 - H371. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1996 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |